Page last updated: 2024-09-05

scutellarin and Colitis-Associated Cancer

scutellarin has been researched along with Colitis-Associated Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, L; Liu, M; Meng, X; Ren, S; Sun, Q; Xu, H; Yang, H; Zeng, S; Zhao, H	1

Other Studies

1 other study(ies) available for scutellarin and Colitis-Associated Cancer

Article	Year
Scutellarin ameliorates colitis-associated colorectal cancer by suppressing Wnt/β-catenin signaling cascade. European journal of pharmacology, 2021, Sep-05, Volume: 906 Topics: Animals; Apigenin; Azoxymethane; Carcinogenesis; Colitis-Associated Neoplasms; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Glucuronates; HT29 Cells; Humans; Male; Mice; Wnt Signaling Pathway	2021

Article

Year

Scutellarin ameliorates colitis-associated colorectal cancer by suppressing Wnt/β-catenin signaling cascade.

European journal of pharmacology, 2021, Sep-05, Volume: 906

Topics: Animals; Apigenin; Azoxymethane; Carcinogenesis; Colitis-Associated Neoplasms; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Glucuronates; HT29 Cells; Humans; Male; Mice; Wnt Signaling Pathway

2021